Related Experiment Video

Updated: May 6, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

5.6K

[Advance in the study of myocardial ischemic preconditioning and postconditioning and the clinical applications]

Yu-Jie Wu1, Lian-Hua Fang, Guan-Hua Du

  • 1Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|October 19, 2013
PubMed

Insights

Myocardial ischemic preconditioning and postconditioning protect the heart by reducing infarct size and improving function. These methods are safe and effective for preventing and treating heart conditions.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Cellular Biology

Background:

  • Myocardial ischemia reperfusion injury is a significant clinical problem.
  • Ischemic preconditioning and postconditioning are protective strategies against this injury.
  • Clinical applications have demonstrated the safety and efficacy of these interventions.

Purpose of the Study:

  • To review the protective mechanisms of ischemic preconditioning and postconditioning.
  • To summarize recent clinical research on these myocardial protection methods.
  • To provide a theoretical basis for novel treatment strategies for ischemic cardiomyopathy.

Main Methods:

  • Literature review of scientific databases.
  • Analysis of studies on myocardial protection mechanisms.
  • Synthesis of recent clinical trial data.

Main Results:

  • Ischemic preconditioning and postconditioning reduce infarct size.
  • These interventions improve myocardial contractility and cell ultrastructure.
  • Arrhythmia incidence is reduced by these protective strategies.

Conclusions:

  • Ischemic preconditioning and postconditioning offer significant myocardial protection.
  • These methods are clinically validated for safety and efficacy.
  • Further research can guide new treatments for ischemic cardiomyopathy.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

11.1K
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.0K

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802